Skip to content

Usability and Tolerability of Novel Protection Device Against Potential Brain Injury During Competitive Sport

Usability and Tolerability of Novel Protection Device Against Potential Brain Injury During Competitive Sport

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03318822
Enrollment
200
Registered
2017-10-24
Start date
2017-08-01
Completion date
2020-12-31
Last updated
2021-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Traumatic, Brain Injury Traumatic Mild

Keywords

brain injury

Brief summary

The purpose of the study is to assess the usability and tolerability of this jugular vein compression device in a population of helmeted and non-helmeted competitive high school, collegiate and professional athletes in the sports of football and rugby. This study differs from previous work in that it is designed to capture additional data related to the athlete experience wearing the jugular vein compression device in older and more elite playing levels.

Detailed description

Significant morbidity, mortality, and related costs are caused by traumatic brain injury (TBI). A simple, effective, and lightweight device worn by athletes or war fighters in the field, designed to mitigate TBI resulting from blast trauma or concussive events, would save lives, and the huge costs incurred for life-treatment of surviving victims. An externally-worn medical device that applies mild jugular compression according to the principle of the Queckenstedt Maneuver (the Device) is being developed by Q30 Sports Science, LLC (Q30). Preliminary research suggests that the Device has the potential to reduce the likelihood of TBI. The currently developed collar has been approved for studies in humans and the results indicate safety for use during high demand and maximal exertion activities. Regarding safety, the externally worn collar is meticulously designed to mimic the body's own omohyoid muscle actions upon the jugular veins that will provide similar pressure and volume increases not to surpass that of a yawn or the mere act of just lying down. This study will investigate the tolerability of this device in athletes participating in the competitive sports of football and rugby at the high school, collegiate or professional levels.

Interventions

DEVICEQ-Collar

An externally-worn medical device that applies mild jugular compression

Sponsors

Children's Hospital Medical Center, Cincinnati
CollaboratorOTHER
Emory University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Normal healthy volunteer * Able to provide written consent * Must be 14 years or older and a participant in collegiate/professional sports of football or rugby

Exclusion criteria

* Unable to provide written consent * History of neurological deficits, previous cerebral infarction, or severe head trauma as indicated through pre-season screening: * Medical contraindications to restriction of venous outflow via the internal jugular veins (known increased intracerebral pressure, metabolic acidosis or alkalosis) * Glaucoma (Narrow Angle or Normal Tension) * Hydrocephalus * Recent penetrating brain trauma (within 6 months) * Known carotid hypersensitivity * Known increased intracranial pressure * Central vein thrombosis * Any known airway obstruction * Any known seizure disorder

Design outcomes

Primary

MeasureTime frameDescription
Tolerability of collar usage1 yearmeasure subject tolerability to wearing the device via weekly survey

Secondary

MeasureTime frameDescription
Compliance of collar usage1 yearmeasure subject compliance to wearing the device via weekly survey completion

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026